CIK 0001805385 · Non-accelerated filer
Evolv Technologies Holdings, Inc.
Sign in to watch- Ticker
- EVLV
- Exchange
- Nasdaq
- Industry
- Computer Peripheral Equipment, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 844473840
- Phone
- 781-374-8100
- Business address
- 500 TOTTEN POND ROAD, 4TH FLOOR, WALTHAM, MA, 02451
- Former names
- NewHold Investment Corp.
- Open-market buys, last 90 days
- $296,479
- in 3 filings
- Open-market sales, last 90 days
- $451,404
- in 1 filing, $451K under 10b5-1 plans
Net −$154,925. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Chitkara Anil Founder & Chief Growth Officer | Option exercise | +37,878 | 1,412,321 | ||
| 2026-03-01 | Chitkara Anil Founder & Chief Growth Officer | Option exercise · Restricted Stock Units | −53,430 | 0 | ||
| 2026-03-01 | Chitkara Anil Founder & Chief Growth Officer | Option exercise · Restricted Stock Units | −45,913 | 45,915 | ||
| 2026-03-01 | Chitkara Anil Founder & Chief Growth Officer | Option exercise · Restricted Stock Units | −37,878 | 75,758 | ||
| 2026-03-01 | Ellenbogen Michael Director | Option exercise | +57,392 | 2,141,353 | ||
| 2026-03-01 | Ellenbogen Michael Director | Option exercise | +50,505 | 2,191,858 | ||
| 2026-03-01 | Ellenbogen Michael Director | Option exercise | +66,787 | 2,258,645 | ||
| 2026-03-01 | Ellenbogen Michael Director | Option exercise · Restricted Stock Units | −66,787 | 0 | ||
| 2026-03-01 | Ellenbogen Michael Director | Option exercise · Restricted Stock Units | −57,392 | 57,392 | ||
| 2026-03-01 | Ellenbogen Michael Director | Option exercise · Restricted Stock Units | −50,505 | 101,010 | ||
| 2026-02-17 | Ellenbogen Michael Director | Option exercise 10b5-1 | +80,745 | $0.24 | $19K | 2,164,706 |
| 2026-02-17 | Ellenbogen Michael Director | Sale 10b5-1 | −80,745 | $5.47 | $442K | 2,083,961 |
| 2026-02-17 | Ellenbogen Michael Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −80,745 | 1,219,994 | ||
| 2026-02-12 | Kuhl Henrik Director | Grant or award · Restricted Stock Units | +9,291 | 9,291 | ||
| 2026-01-16 | Ellenbogen Michael Director | Option exercise 10b5-1 | +80,745 | $0.24 | $19K | 2,164,706 |
| 2026-01-16 | Ellenbogen Michael Director | Sale 10b5-1 | −80,745 | $6.20 | $501K | 2,083,961 |
| 2026-01-16 | Ellenbogen Michael Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −80,745 | 1,300,739 | ||
| 2026-01-05 | Kedzierski John President & CEO | Sale | −74,322 | $7.03 | $522K | 140,678 |
| 2026-01-02 | Kedzierski John President & CEO | Option exercise | +207,000 | 215,000 | ||
| 2026-01-02 | Kedzierski John President & CEO | Option exercise · Restricted Stock Units | −207,000 | 414,000 |
Page 4 of 27 · 526 trades